Particle Data Platform

Case 344: Amerithrax

6/27/20262 hr

In the tense weeks following the September 11 terror attacks in 2001, a new and invisible threat emerged across the United States. Letters laced with weaponised anthrax began arriving through the mail, infecting ordinary people and spreading fear nationwide.

As the possibility of bioterrorism gripped the country, a massive federal investigation codenamed Amerithrax was launched to uncover who was behind the attacks…

---

Narration – Anonymous Host

Research & writing – Milly Raso

Production & music – Mike Migas

Audio editing – Anthony Telfer

Sign up for Casefile Premium:

For all credits and sources, please visit https://casefilepodcast.com/case-344-amerithrax


Hosted on Acast. See acast.com/privacy for more information.

Transcript preview

First 90 seconds
  1. Anonymous Host· Host0:00

    For early access and ad-free episodes, check out our Patreon, Apple Premium, and Spotify subscription memberships. [heartbeat] Our episodes deal with serious and often distressing incidents. If you feel at any time you need support, please contact your local crisis center. For suggested phone numbers for confidential support and for a more detailed list of content warnings, please see the show notes for this episode on your app or on our website. [suspenseful music] Retirement didn't suit 63-year-old photojournalist, Robert Stevens. He lasted just six months before boredom drove him back to his beloved former job as a photo editor at The Sun tabloid newspaper. By October 2001, Robert was settling back into the routine at the paper's editorial headquarters in Boca Raton, Florida, when he was struck down by a persistent illness. Suffering from fever, chills, nausea, vomiting, and intense muscle aches, Robert assumed he had come down with a particularly severe strain of the flu.

We value your privacy

We use cookies to understand how you use our platform and to improve your experience. Click "Accept All" to consent, or "Decline non-essential" to opt out of non-essential cookies. Read our Privacy Policy.